Search
- Cost Estimate
As reported by the Senate Committee on Health, Education, Labor, and Pensions on October 4, 2023
- Cost Estimate
As reported by the Senate Committee on Health, Education, Labor, and Pensions on October 4, 2023
- Cost Estimate
As reported by the Senate Committee on Health, Education, Labor, and Pensions on July 27, 2023
- Cost Estimate
As reported by the Senate Committee on Health, Education, Labor, and Pensions on July 27, 2023
- Cost Estimate
As reported by the House Committee on Energy and Commerce on August 25, 2023
- Report
In response to a request from Budget Committee Chairman Jodey Arrington and Congressman Michael C. Burgess, CBO provides information about its analysis of federal policies that affect the development of new drugs in the United States.
- Blog Post
To enhance its work for the Congress, CBO is looking for new research that examines how changes in pharmaceutical companies’ expected future profits affect the development of new drugs and health outcomes.
- Cost Estimate
As reported by the Senate Committee on Health, Education, Labor, and Pensions on July 26, 2023
- Cost Estimate
As introduced on July 25, 2023
- Presentation
Presentation by Elizabeth Ash, William Carrington, Rebecca Heller, and Grace Hwang of CBO’s Labor, Income Security, and Long-Term Analysis and Health Analysis divisions to the Children’s Health Group, American Academy of Pediatrics.